Marrone bio innovations receives nasdaq notice regarding failure to satisfy a continued listing rule

Davis, calif., nov. 08, 2021 (globe newswire) -- marrone bio innovations, inc. (nasdaq: mbii) today announced that it has received a letter from the listing qualifications department of the nasdaq capital market notifying the company of its noncompliance with nasdaq listing rule 5550(a)(2) as a result of the company's closing bid price being below $1.00 per share for 30 consecutive days.
MBII Ratings Summary
MBII Quant Ranking